Despite a highly profitable business model and a strong position in the medical aesthetics industry, INMD stock is down -33% over the last 12 months. Macroeconomic pressures, political risks in InMode ...
DUBLIN--(BUSINESS WIRE)--The "Body Contouring Devices Market Size, Share & Trends Analysis Report by Type (Noninvasive and Minimally Invasive Devices, Invasive Devices), by Application, by Region, and ...
Despite INMD being down -22% since I recommended to Buy the stock in March, InMode Ltd. remains a highly profitable & innovative leader in the aesthetic industry. Stronger than expected macroeconomic ...
NEW YORK, Jan. 20, 2020 /PRNewswire/ -- bodySCULPT® the premier plastic surgery practice based in New York City, NY, announces two breakthrough non-invasive solutions from InMode - EVOKE, a complete ...
InMode Ltd. (INMD) is a leading provider of innovative, energy-based, minimally-invasive surgical medical treatment solutions internationally. Within the esthetics market, InMode's products and ...
The body contouring treatments market is segmented based on technology into invasive and non-invasive technologies—the non-invasive segment is expected to hold major share of the market in 2023. The ...
LAKE FOREST, California, June 16, 2020 /CNW/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is proud to announce Health Canada certification of ...
The market for cosmetic surgery-related procedures is worth over $63 billion annually and is growing fast. InMode is gaining a share of the aesthetics market, with proprietary devices and workstations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results